A big company called Palantir made a deal with the NHS to help them use their patient information better. But some people are worried about how Palantir will use this information and if they will keep it safe. Palantir tried to make people feel better by saying they support the NHS and are not selling any patient data, but they did it without asking the NHS first. Now the NHS is looking into whether Palantir broke their deal and if they can still be trusted with private medical information. Read from source...

- The title is misleading and sensationalized, implying that Palantir breached a contract with NHS, when in fact the report is based on an allegation from a marketing campaign that never happened.
- The article relies heavily on the perspective of Patient advocacy groups, especially the Good Law Project, which has a clear agenda against Palantir and its data handling practices, without presenting any counterarguments or evidence to support their claims.
- The article uses vague and inflammatory language such as "scrutiny", "breach", "allegations", "controversy" to create a negative tone and influence the readers' perception of Palantir, without providing factual details or context about the situation.
- The article fails to mention that Palantir is not working with Topham Guerin anymore, which could imply that they are still involved in the marketing campaign that was allegedly breached.
- The article also omits important information such as the contract terms and conditions, the nature of the marketing campaign, the role of Accenture Plc, and Palantir's response to the Good Law Project's accusations, which could provide a more balanced and informative view of the issue.
- The article implies that Palantir is only working with NHS for financial gain, by mentioning the £330 million value of the contract, without acknowledging the potential benefits of the Federated Data Platform for the NHS and its patients, such as improving efficiency, coordination, and quality of care.

Negative

Summary:
Palantir Technologies is facing scrutiny over allegations of a contract breach with the NHS, according to a report. The company is accused of launching a marketing campaign that referenced the NHS without prior consent. Patient advocacy groups have expressed concerns about Palantir's involvement in handling private medical data.